Case report: an unexpected link between partial deletion of the SHANK3 gene and Heller’s dementia infantilis, a rare subtype of autism spectrum disorder by Philippe, Anne et al.
Case report: an unexpected link between partial
deletion of the SHANK3 gene and Heller’s dementia
infantilis, a rare subtype of autism spectrum disorder
Anne Philippe, Yann Craus, Marle`ne Rio, Nadia Bahi-Buisson, Nathalie
Boddaert, Vale´rie Malan, Jean-Paul Bonnefont, Laurence Robel
To cite this version:
Anne Philippe, Yann Craus, Marle`ne Rio, Nadia Bahi-Buisson, Nathalie Boddaert, et al.. Case
report: an unexpected link between partial deletion of the SHANK3 gene and Heller’s dementia
infantilis, a rare subtype of autism spectrum disorder. BMC Psychiatry, BioMed Central, 2015,
15 (1), pp.256. <10.1186/s12888-015-0631-6>. <inserm-01264489>
HAL Id: inserm-01264489
http://www.hal.inserm.fr/inserm-01264489
Submitted on 29 Jan 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

CASE REPORT Open Access
Case report: an unexpected link between
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Abstract
Background: Deletions and mutations involving the SHANK3 gene lead to a nonspecific clinical presentation with
moderate to profound intellectual disability, severely delayed or absent speech, and autism spectrum disorders (ASD).
Better knowledge of the clinical spectrum of SHANK3 haploinsufficiency is useful to facilitate clinical care monitoring
and to guide molecular diagnosis, essential for genetic counselling.
Case presentation: Here, we report a detailed clinical description of a 10-year-old girl carrying a pathogenic
interstitial 22q13.3 deletion encompassing only the first 17 exons of SHANK3.
The clinical features displayed by the girl strongly suggested the diagnosis of dementia infantilis, described by
Heller in 1908, also known as childhood disintegrative disorder.
Conclusion: Our present case confirms several observations according to which regression may be part of the
clinical phenotype of SHANK3 haploinsufficiency. Therefore, we think it is crucial to look for mutations in the gene
SHANK3 in patients diagnosed for childhood disintegrative disorder or any developmental disorder with a regressive
pattern involving social and communicative skills as well as cognitive and instinctual functions, with onset
around 3 years.
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Background
Deletions and mutations in the SHANK3 gene have
been repeatedly found when screening cohorts of pa-
tients assessed for autism spectrum disorder [1–3],
for pervasive developmental disorder not otherwise speci-
fied (PDD-NOS) [4], for schizophrenia [5], for non-
syndromic intellectual disability [6] and for symptomatic
continuous spike and waves during slow-wave sleep syn-
drome [7].
Patients with SHANK3 haploinsufficiency exhibit an
unspecific clinical profile with moderate to profound in-
tellectual disability, severely delayed or absent speech,
hypotonia, and autism spectrum traits [1–3].
The SHANK3 gene codes for a scaffold protein in the
postsynaptic densities (PSD) of excitatory glutamatergic
synapses in the central and peripheral nervous system
[1]. The protein complex organized by SHANK3 per-
forms different functions in the postsynaptic membrane
including actin-based cytoskeletal remodelling, synapse
formation, AMPA receptor endocytosis, and regulation
of synaptic transmission and plasticity. SHANK3 mutant
mice show a loss of spines, a reduction in spine volume,
and decreased PSD thickness in the adult, suggesting a
phenotype of reduced or delayed synapse maturation [8].
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Here, we report a detailed clinical description of a
10-year-old girl presenting with a short interstitial
22q13.3 deletion encompassing only the first 17 exons
of the SHANK3 gene, similar to that of another patient
(arr 22q13.33 (51,080,647–51,137,385)x1 dn, hg19) and
previously reported as pathogenic in Bonaglia et al.
(Patient 37) and in Figura et al. (Patient 4) [9, 10].
Our objective was to improve knowledge about the
developmental course of SHANK3 haploinsufficiency in
order to facilitate clinical care monitoring and to help
in molecular diagnosis, essential for genetic counselling.
Indeed, novel SHANK3 variants are more and more
often detected in individuals with unexplained develop-
mental delay or ASD, as a result of the increasing use
of next-generation sequencing in routine genetic diag-
nosis (syndrome-targeted panel, whole exome or whole
genome sequencing) [11, 12]. However, interpretation
of these novel SHANK3 variants is challenging. Patho-
genicity assessment is based on family co-segregation,
functional predictions, the degree of conservation of
amino-acids and also on the analysis of precise pheno-
typical descriptions [1, 13, 14].
Regression may be an important feature of SHANK3
haploinsufficiency, as suggested by recent case reports
pinpointing behavioural regression during the life course
of patients with an unstable mood disorder, together with
a progressive loss of skills during adolescence [15, 16] or
in adulthood [17, 18].
Here, we report for the first time the case of a 10-
year-old girl presenting a childhood disintegrative disorder
also known as Heller’s dementia infantilis, associated with
a deletion in the SHANK3 gene.
Case presentation
L. is the second child of first-degree-related healthy
parents born in Algeria. Her parents separated when
she was 18 months old and she has had no further con-
tact with her father since she was 6. She was born
through vaginal birth at full term (BW = 3.570 kg; BS =
51.5 cm; HC = 35 cm; Apgar = 10/10). She experienced
a slowing of the embryonic cardiac rhythm during de-
livery, and recovered quickly. According to her mother,
L.’s psychomotor and social development were in the
normal range until 2 years of age; she did not notice
any difference compared to the early infancy of her son,
aged 10: good early interactions, appropriate eye con-
tact, development of appropriate imitation, babbling,
shared attention skills and use of functional objects.
She was able to sit when she was 6 months old, started
to walk at 12 months. Babbling was present before 12
months; she was able to duplicate syllables at 9 months,
to pronounce her first words at 10 months (daddy, nanny),
and first associations of words around 18 months.
When she was 2 years old, she could use a few words
appropriately (bread, cookies, bread, hello, thanks, more,
the names of her brother and sister). However, progress in
language was slow, and L. never produced any sentence.
Toilet-training was acquired by day and night around 2
years of age, and lost gradually from the age of 5.
L. came to the attention of the school teacher as
soon as she started to go to school, when she was in
her fourth year, because she was not progressing. Her
language was very poor, and she had difficulty focusing
her attention. She started to see a child psychiatrist, a
psychologist and a psychomotor therapist. Despite these
therapies, she became more and more agitated during the
second and the third year of school, so that she needed a
school assistant. In the same period L. became socially
withdrawn: she no longer played with her peers, did
not follow the teacher’s instructions either. At home,
her activities became more impoverished. She enjoyed
making noises with car games, and liked undressing her
dolls. Between 5 and 6 years of age, L. experienced
three sudden episodes at three different times when she
had fever, characterized by extreme fear, followed by a
fall onto her knees without loss of consciousness. These
episodes were interpreted as febrile seizures, and were
treated with sodium valproate after the third episode,
although no electroencephalogram (EEG) was available
during the crisis, and no abnormality was detected on
EEGs between the episodes. According to her mother,
after these episodes, L.’s state worsened, with loss of
language skills, loss of toilet-training, and aggravation
of her agitation. Monotherapy with methylphenidate
was introduced to decrease the agitation but caused tol-
erance problem: the agitation worsened, and L. started
to bite her tongue. Risperidone was then prescribed at
1mg but caused loss of tonus and falls; lower doses of
risperidone provided no clinical improvement and were
discontinued.
Clinical assessment
Clinical features were explored and a quantitative as-
sessment was conducted in our outpatient clinic when
the child was 7 years of age, and this evidenced poor
developmental and adaptive skills. Behavioural obser-
vations were conducted during a 12-day stay in a free
play setting with 5 other children, and through indi-
vidualized assessments using the Psycho-Educative Profile
and the Brunet-Lezine Scales. Scoring of the Child Autism
Rating Scale was performed jointly by a psychiatrist, a
psychologist, and a nurse at the end of the 12-day period
of observation.
In the area of social interaction: L. was unable to
point to indicate her needs, although she had been
able to do it in the past according to her mother. She
was able to make eye contact, but only for a few sec-
onds, mostly on her own initiative. She expressed
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very few facial emotions, and she communicated by
screaming. She was not interested in other children,
but did not avoid them, whereas she liked to be close
to adults. She was not interested in developing peer
relationships.
In the area of communication: Her language was lim-
ited to a few words (yes, no, water), and she was not able
to compensate by alternative modes of communication
such as gesture or mime. She could not follow verbal in-
structions, nor imitate. She did not show interest in
dolls, nor in pretend or symbolic play.
In the area of behaviours, interests and activities: We
noted a short attention span, and rapid shifts from one
uncompleted activity to another. She mainly engaged in
low-grade repetitive activities, such as easy nesting games
or playing with water. Incessant restlessness associated
with clumsiness made her bump into objects or people
and endanger herself because she failed to anticipate the
consequences of her movements. She reacted to minor
changes in her environment or to transitions from one ac-
tivity to another by a worsening of her agitation, and in-
duced vomiting. We observed pervasive eating disorders,
including merycism, pica, and induced vomiting. L. would
push objects deep inside her mouth or nose, keep her
vomit in her mouth and swallow it again, causing disgust
and rejection. However, she never showed any aggressive
behaviour, towards herself or others, and had neither
stereotyped movements nor rituals of persistent pre-
occupation with parts of objects.
On the Autism Diagnostic Interview- Revised (ADI-R)
[19], she scored in the domain of reciprocal social inter-
action (20 > 10), communication (13 > 7), but not in the
area of repetitive behaviours and stereotyped patterns
(2 < 3) (Table 1). The total Child Autism Rating Scale
score (CARS) [20] was 44. 5 (severely autistic) (Table 2).
It was not possible to obtain a developmental profile
with the Psycho-Educative Profile (PEP-R) [21] because
of her agitation and lack of participation. On the
Brunet-Lézine Scale [22], her developmental profile was
heterogeneous, with developmental ages ranging from
14 months on language and socialization items, to 18
months on visuo-manual prehension coordination, and
42 months for global motor development. Neuropsy-
chomotor assessment using standardized batteries [23]
revealed impairments and delays for global motor devel-
opment, visuo-manual prehension coordination, posturo-
motor and locomotion acquisitions (static and dynamic
balance). She was unable to draw a stick figure or a circle.
Evolution
The agitation and gastrointestinal symptoms got worse.
Therefore, we reintroduced treatment with risperidone 1
mg per day, with no effect. Risperidone was discontinued,
and cyamemazine was introduced at low doses (10 mg),
but her state did not improve. Her mother described
the occurrence of 3 new episodes associating extreme
fear and paleness without fever, separated by a few
months, leading the neuropaediatrician to introduce a
treatment with carbamazepine, despite a normal EEG.
L. was then hospitalized for treatment adjustment in
a full-time hospitalization unit. Digestive investigations
showed gastro-oesophageal reflux, treated with omepra-
zole. The induced vomiting, merycism and pica improved.
However, the agitation was still very great, and the regres-
sion in language and autonomy were persistent. By the
Table 1 Autistic diagnostic interview-revised (ADI-R) scores
ADI-R domains Scores
Reciprocal social interactions 20
-Failure to use nonverbal behaviors
to regulate social interaction
2
-Failure to develop peer relationships 7
-Lack of shared enjoyment 4
-Lack of socio-emotional reciprocity 7
Language and Communication 13
-Lack of, or delay in, spoken language
and failure to compensate through gestures
7
-Lack of varied spontaneous make-believe play 6





to nonfunctional routines or rituals
0
-Stereotyped and repetitive motor mannerisms 1
-Preoccupations with part-objects
or non-functional elements of materials
1






Object use relationship to people 3,5
Fear and nervousness 3,5
General Impression 3,5
Body use 3
Adaptation to change 3
Non-verbal communication 3
Activity level 3
Relations to others and visual response 2,5
Listening response 2
Level and consistency of intellectual response 2
Global score 44,5
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time she was 10, she had completely lost her language
abilities. She was extremely agitated, could not remain
seated to eat. She still exhibited very frequent vomiting
and merycism, would chew the sleeves of her pullover,
pieces from jigsaw puzzles, and push them deep into
her throat. She needed to wear diapers since she had
completely lost toilet training, she would play with her
dirty diapers and spread her faeces on the ground. She
displayed sleep disorders, with difficulty falling asleep
and frequent night-awakenings. The agitation, eating
disorders and sleep problems were stabilized with con-
tinuation of a treatment associating risperidone (2mg),
cyamemazine (25mg), carbamazepine (200mg), and omep-
razole (10mg). However, her imitation and shared atten-
tion skills remained very limited. She continued to initiate
the same repetitive activities, and paid little attention to
other children.
Physical assessment
Physical examination revealed no dysmorphic features.
No auditory or visual impairment was found. The patient’s
growth parameters were within the normal range.
Neurophysiological investigations
EEG showed no seizure activity and there was no overt
clinical seizure episode after the febrile seizure episodes
at 5 years of age.
The cerebral magnetic resonance imaging (MRI) scan
at 8 years of age showed a thin corpus callosum in the
posterior part, hyper intensity on T2-weighted images
localized in the hippocampus, and sub-cortical hyperin-
tensity on T2-weighted images localized in the temporal
lobes (bilateral temporal gliosis).
Genetic investigations
The patient had a first genetic screening which in-
cluded karyotyping, screening for expansion of the CGG
repeat sequence in the 5′ untranslated region of the
FMR1 gene and for mutations of the MECP2 gene, using
Sanger sequencing. This was followed up with general and
metabolic screening (blood count and red cell parameters,
blood urea, serum creatinine and electrolytes, liver func-
tion tests, thyroid function tests, levels of serum lactate,
serum ammonia, serum lead, serum lactate and pyruvate,
serum creatine and CPK, gas chromatography of blood
and urine to screen for congenital metabolic disorders
such as aminoacidaemia, organic acidaemia, and fatty acid
oxidation disorders. No abnormality was found. We then
performed an array comparative genomic hybridization
(CGH) analyses which revealed a 22q13.3 deletion of 40, 8
kb (arr 22q13.3 (51,104,485-51,145,359)x1, hg19; NCBI
build 37). Quantitative PCR (Polymerase Chain Reaction)
and MLPA (Multiple Ligation Probe-dependent Amplifi-
cation) of SHANK3 gene confirmed the deletion. Data
analyses indicated a deletion encompassing the first 17
exons of the SHANK3 gene (Fig. 1). Only the mother
was available for testing; she did not carry her daughter’s
deletion.
Discussion
We report the case of a girl carrying a 22q13.3 micro-
deletion restricted to the first 17 exons of the SHANK3
gene. The clinical features displayed by the girl strongly
suggested the diagnosis of dementia infantilis, a devel-
opmental disorder described in 6 children by Heller in
1908 [24], characterized by (1) onset between 3 and 4
years of age after a period of apparently normal devel-
opment, (2) a severe regression with the progressive
loss or marked impairment of spoken language, loss of
play, loss of social skills, and loss of bowel and bladder
control, (3) a prodromal period of behavioural disrup-
tion with extreme agitation, fearfulness and (possibly)
hallucinations and (4), a poor outcome with severe in-
tellectual deterioration.
Indeed, one of the most important features presented
by this case is the regressive pattern of her symptoms,
with the progressive loss after the age of 3 years of her
developmental and socialization skills, leading to severe
adaptive impairment at 10 years. This developmental
regression concerned not only the progressive loss of
cognitive abilities such as language, socialization and
attention, but also the loss of previously mastered auto-
mated functions: loss of toilet-training, pica, induced
vomiting, merycism and sleep disorders. Furthermore,
the regression was preceded in our patient by a pro-
dromal phase characterized by behavioural disruption
(restlessness and excitement, extreme agitation, short
attention span with rapid shifts from one uncompleted
activity to another), and the occurrence of acute epi-
sodes of extreme fearfulness associated with motor and
Fig. 1 Representation of the 17 exons deletion of the SHANK3 gene
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neuro-vegetative symptoms, sometimes in a context of
fever. The state of our patient progressively worsened
after each episode. According to Westphal et al. [25],
these episodes of extreme fear preceding a developmen-
tal regression are specific to Heller’s syndrome.
These acute episodes were first interpreted as partial
epileptic frontal seizures. However, no abnormality was
recorded on waking EEG in our patient, but we could
not obtain a resting EEG because of her agitation. Inter-
estingly, Figura et al. [10], in 6 patients with 22q13.3 dele-
tion, reported a particular EEG pattern, characterized by
multifocal paroxysmal EEG abnormalities, predominant
over the frontal-temporal regions, activated during sleep.
Dementia infantilis was included in DSM IV under the
heading childhood disintegrative disorder (CDD), with
less stringent diagnostic criteria, especially with regard
to age at onset (up to the age of 10 years). Our patient
fulfilled the diagnostic criteria for CDD, in particular
given the period of the first 2 years of normal develop-
ment (walking at 12 months, first words at 10 months,
first associations at 18 months and toilet-training by day
and night around 2 years of age). The later regression of
expressive and receptive language, social skills, bowel
and bladder control, play and motor skills after the age
of three, leading to qualitative impairment in social
interaction, qualitative impairment in communication,
and restricted, repetitive, and stereotyped patterns of be-
haviour indeed contribute to the definition of CDD.
The clinical case shown here could lead to several dif-
ferential diagnoses. We eliminated the diagnosis of autis-
tic disorder because L. did not have ritualized patterns
of nonverbal behaviour. Criteria for Rett’s syndrome
were not fulfilled since L. did not show a deceleration of
head growth or stereotyped hand movements, and did
not have mutations in the MECP2 gene. Pervasive de-
velopmental disorder not otherwise specified is not a
candidate diagnosis either since this category should
be used when criteria are not met for a specific per-
vasive developmental disorder, like Childhood Disinte-
grative Disorder. Intellectual deficiency was associated
with the diagnosis but could not explain the regres-
sive pattern of the symptomatology, nor the presence
of significant impairment in social functioning.
Childhood disintegrative disorder is extremely rare with
an incidence of 1.7 in 100,000 children [26]. So far, very
little is known on the genetic or metabolic factors asso-
ciated with this specific condition, among which vitamin
B12 deficiency [27] or anti-NMDA-receptor encephalitis
[28]. Interestingly, SHANK3 is a post-synaptic density
protein involved in N-methyl-d-aspartate (NMDA) re-
ceptor tethering and dendritic spine rearrangement [29].
In addition, our case shares the same clinical features
as other SHANK3 deletion cases described in the litera-
ture: severe language impairment with impairment of
social interactions, impairment of verbal and nonverbal
communication, presence of sensory processing dys-
function involving touching and oro-facial activities,
developmental delay and intellectual deficiency, hyper-
activity and attention disorder, gastrointestinal symp-
toms and thin corpus callosum on cerebral MRI [3, 30].
Interestingly, severe regression in both language and
social skills and adaptive functions (loss of motor skills,
loss of independent eating and dressing, anorexia, loss of
weight and urinary incontinence) have previously been
reported in patients at different stages in development
with a partial deletion or a single mutation of SHANK3
gene [3, 9]: during childhood [11, 12, 31], in adolescence
[1, 15, 16, 32] or in adulthood [17, 18].
Our case report confirms that regression may be part
of the clinical phenotype and is perhaps a hallmark
symptom of SHANK3 haploinsufficiency, particularly in
cases with a partial deletion or a single mutation.
Limitations
One limitation to this observation is related to the fact
that there was no home video to check that the devel-
opment of L. was normal prior to the age of 2. How-
ever, the information in the mandatory child health
data completed by the paediatricians confirmed that
L.’s development was normal during the two first years
of life. Another limitation is the fact that we could not
obtain DNA from the father. However, we are confident
about the pathogenicity of the deletion we describe,
because deletions similar in position and size have
already been described in patients: - Denayer et al. [17]
reported a deletion of SHANK3 encompassing the first
19 exons associated with bipolar disorder with progres-
sive loss of skills in one of their 7 patients (patient 1);
Bonaglia et al. [9] among their 44 patients, described
two patients presenting small deletions encompassing
the first 17 exons (patient P 37) and the first 9 exons
(patient P44) respectively of the SHANK3 gene, associ-
ated with Phelan-McDermid syndrome; patient P37 also
exhibited a progressive loss of skills [10]. Finally, several
cases of regression in language and behaviour after the age
of 2 have been described in association with SHANK3mu-
tations [11, 12, 31].
Conclusion
In conclusion, we describe for the first time a partial de-
letion of the SHANK3 gene associated with a clinical
profile of childhood disintegrative disorder or Heller’s
syndrome. We think it is crucial to carefully describe the
timing of the appearance of autistic features in children,
and to search for SHANK3 mutations in patients diag-
nosed with childhood disintegrative disorder or any de-
velopmental disorder with a regressive pattern involving
social and communicative skills as well as cognitive and
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automated functions, with onset around 3 years. Indeed,
genetic diagnosis of SHANK3 haploinsufficiency is import-
ant for both genetic counselling and care monitoring.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor of this journal.
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